FACTOID # 15: A mere 0.8% of West Virginians were born in a foreign country.
 
 Home   Encyclopedia   Statistics   States A-Z   Flags   Maps   FAQ   About 
 
WHAT'S NEW
RELATED ARTICLES
People who viewed "Fluticasone" also viewed:
 

SEARCH ALL

FACTS & STATISTICS    Advanced view

Search encyclopedia, statistics and forums:

 

 

(* = Graphable)

 

 


Encyclopedia > Fluticasone

Fluticasone chemical structure
Fluticasone proprionate Fluticasone propionate structure. ...

6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-
(1-oxopropoxy)-androsta-1,4-diene-17-carbothioic acid (6α,11β,16α,17α)-
S-(fluoromethyl) ester
CAS number
90566-53-3 or 80474-14-2 (with proprionate)
ATC code
D07AC17, R01AD08, R03BA05
Chemical formula C22-H27-F3-O4-S or C25-H31-F3-O5-S (with proprionate)
Molecular weight 444.511 or 500.575 (with proprionate)
Bioavailability 0.51% (Intranasal)
Metabolism Intranasal- hepatic cytochrome p450,3A4
Elimination half-life 7.8 hours
Excretion renal
Pregnancy category Category C for Intranasal and Inhaled
Legal status  ?
Routes of administration Intranasal, Inhaled, Topical Cream or Ointment

Fluticasone proprionate is a glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. CAS registry numbers are unique numerical identifiers for chemical compounds, polymers, biological sequences and alloys. ... The Anatomical Therapeutic Chemical Classification System is used for the classification of drugs. ... A chemical formula (also called molecular formula) is a concise way of expressing information about the atoms that constitute a particular chemical compound. ... The molecular mass of a substance (less accurately called molecular weight and abbreviated as MW) is the mass of one molecule of that substance, relative to the unified atomic mass unit u (equal to 1/12 the mass of one atom of carbon-12). ... In pharmacology, bioavailability is a term used to describe a pharmacokinetic property of drugs, namely, the fraction of a dose which reaches the systemic circulation. ... The elimination half-life of a drug (or any xenobiotic agent) refers to the timecourse necessary for the quantity of the xenobiotic agent in the body (or plasma concentration) to be reduced to half of its original level through various elimination processes. ... --212. ... The pregnancy category of a pharmaceutical agent is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother. ... The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. ... Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger similar effects. ... For the play, see Hay Fever. ...


The precise mechanisms of glucocorticoid action in asthma are unknown. Inflammation is recognized as an important component in the pathogenesis of asthma. Glucocorticoids have been shown to inhibit multiple cell types (e.g., mast cells, eosinophils, basophils, lymphocytes, macrophages, and neutrophils) and mediator production or secretion (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in the asthmatic response. These anti-inflammatory actions of glucocorticoids may contribute to their efficacy in asthma. Typically, however, the action on the cells affected requires several days. Therefore, inhaled steroids are not used for immediate relief of asthma, but instead as preventive and maintenance therapy.


Clinical trials

This listing is NOT complete and should NOT be construed as support for treatment decisions. See also PubMed clinical manuscripts referring to fluticasone

  • Burge, P.S.; Calverley, P.M.; Jones, P.W.; Spencer, S.; Anderson, J.A.; and Maslen T.K. (2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. British Medical Journal 320 (7245), 1297-1303. PMID 10807619.
  • Paggiaro, P.L.; Dahle, R.; Bakran, I.; Frith, L.; Hollingworth, K.; and Efthimiou, J. (1998). Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. The Lancet 351 (9105), 773-780. PMID 9519948.
both support a positive outcome for use of fluticasone in patients with chronic obstructive pulmonary disease, also referred to as COPD

  Results from FactBites:
 
Fluticasone Muscle relaxants Pharmatia Pharmacy: drugs & medicines (1919 words)
* fluticasone inhalation is used to prevent asthma attacks.
fluticasone inhalation is also used in the treatment of chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis.
If your child is on fluticasone therapy, the doctor should periodically check height and weight.
  More results at FactBites »

 
 

COMMENTARY     


Share your thoughts, questions and commentary here
Your name
Your comments

Want to know more?
Search encyclopedia, statistics and forums:

 


Press Releases |  Feeds | Contact
The Wikipedia article included on this page is licensed under the GFDL.
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms, 1022, m